EX-99.1 4 d894295dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

MALLINCKRODT PLC

CONSOLIDATED ADJUSTED EBITDA

(unaudited, in millions)

 

     Three Months
Ended		     Fiscal Year Ended  
     December 27,
2019		     December 27,
2019		  

Net loss

    $ (1,157.1 )    $ (996.5 ) 

Adjustments:

     

Interest expense, net

      74.3       299.5  

Income benefit

      (327.7 )      (584.3 ) 

Depreciation and amortization

      227.6       951.1  

Non-restructuring impairment charges

      274.5       388.0  

Restructuring charges, net

      (12.9 )      (1.7 ) 

Inventory step-up expense

      —         10.0  

Income from discontinued operations

      (3.9 )      (10.7 ) 

Change in contingent consideration fair value

      (36.7 )      (60.2 ) 

Gains on debt extinguishment, net

      (377.4 )      (466.6 ) 

Separation costs

      13.5       63.9  

Significant legal and environmental charges

      1,643.4       1,671.6  

Divestitures

      33.5       33.5  

R&D upfront payment

      —         20.0  

Unrealized gain on equity investment

      (13.7 )      (20.2 ) 
  

 

 

    

 

 

  

Adjusted EBITDA

    $ 337.4     $ 1,297.4  
  

 

 

    

 

 

  

MALLINCKRODT PLC

SPECIALTY GENERICS ADJUSTED EBITDA

(unaudited, in millions)

 

     Three Months
Ended		      Fiscal Year Ended  
     December 27,
2019		      December 27,
2019		  

Segment operating income

    $ 28.0      $ 108.1  

Adjustments:

      

Corporate and unallocated expenses

      0.4        4.3  

Depreciation

      15.0        59.0  
  

 

 

     

 

 

  

Adjusted EBITDA

    $ 43.4      $ 171.4  
  

 

 

     

 

 

  

 

1